Fine-tuning of T lymphocytes in autoimmunity: Genetic association of CTLA-4 variants and Graves' disease revisited

Clinical Endocrinology

Volumn 59, Issue 5, 2003, Pages 555-557

  Badenhoop, Klaus ^a   Seidl, Christian ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME 2Q; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; GENE MAPPING; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYROID DISEASE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; LYMPHOCYTE ACTIVATION; POLYMORPHISM, GENETIC; T-LYMPHOCYTES;

EID: 0242288585     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01863.x     Document Type: Note

References (20)

1. Allahabadia, A., Heward, J.M., Nithyananthan, R, Gibson, S.M., Reuser, T.T.Q., Dodson, P.M., Franklyn, J.A. & Gough, S.C. (2001) The MHC class II region, CTLA-4 gene and ophthalmopathy in patients with Graves' disease. Lancet, 358, 984-985 .
2. Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.C. & Polychronakos, C. (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry, 277, 46478-46486.
3. Bednarczuk, T., Hiromatsu, Y., Fukutani, T., Jazdzewski, K., Miskiewicz, P., Osikowska, M. & Nauman, J. (2003) Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. European Journal of Endocrinology, 148, 13-18.
4. Buzzetti, R., Nistico, L., Signore, A. & Cascino, I. (1999) CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet, 354, 1824.
5. Carreno, B.M. & Collins, M. (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annual Review of Immunology, 20, 29-53.
6. Carreno, B.M., Bennett, F., Chau, T.A., Ling, V., Luxenberg, D., Jussif, J., Baroja, M.L. & Madrenas, J. (2000) CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. Journal of Immunology, 165, 1352-1356.
7. Donner, H., Seidl, C., Braun, J., Siegmund, T., Herwig, J., Seifried, E., Usadel, K.H. & Badenhoop, K. (1998) CTLA4 gene haplotypes can not protect from IDDM in the presence of high risk HLA DQ8 or DQ2 alleles in German families. Diabetes, 47, 1158-1160.
8. Heward, J.M., Allahabadia, A., Armitage, M., Hattersley, A., Dodson, P.M., Macleod, K., Carr-Smith, J., Daykin, J., Daly, A., Sheppard, M.C., Holder, R.L., Barnett, A.H., Franklyn, J.A. & Gough, S.C.L. (1999) The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. Journal of Clinical Endocrinology and Metabolism, 84, 2398-2401.
9. Hudson, L.L., Rocca, K., Song, Y.W. & Pandey, J.P. (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Human Genetics, 111, 452-455.
10. Kinjo, Y., Takasu, N., Komiya, I., Tomoyose, T., Takara, M., Kouki, T., Shimajiri, Y., Yabiku, K. & Yoshimura, H. (2002) Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. Journal of Clinical Endocrinology and Metabolism, 87, 2593-2596.
11. Kouki, T., Sawai, Y., Gardine, C.A., Fisfalen, M.E., Alegre, M.L. & DeGroot, L.J. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology, 165, 6606-6611.
12. Ling, V., Wu, P.W., Finnerty, H.F., Agostino, M.J., Graham, J.R., Chen, S., Jussiff, J.M., Fisk, G.J., Miller, C.P. & Collins, M. (2001) Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics, 78, 155-168.
13. Marron, M.P., Raffel, L.J., Garchon, H.-J., Jacob, C.O., Serrano-Rios, M., Martinez Larrad, M.T., Teng, W.-P., Park, Y., Zhang, Z-X., Goldstein, D.R., Tao, Y.-W., Beaurain, G., Bach, J.-F., Huang, H.-S., Luo, D.-F., Zeidler, A., Rotter, J.I., Yang, M.C.K., Modilevsky, T., MacLaren, N.K. & She, J.-X. (1997) Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Human Molecular Genetics, 6, 1275-1282.
14. Mäurer, M., Loserth, S., Kolb-Mäurer, A., Ponath, A., Wiese, S., Kruse, N. & Rieckmann, P. (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics, 54, 1-8.
15. Maurer, M., Ponath, A., Kruse, N. & Rieckmann, P. (2002) CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis. Journal of Neuroimmunology, 131, 213-215.
16. Riley, J.L., Mao, M., Kobayashi, S., Biery, M., Burchard, J., Cavet, G., Gregson, B.P., June, C.H. & Linsley, P.S. (2002) Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proceedings of the National Academy of Sciences of the United States of America, 99, 11790-11795.
17. Seidl, C., Donner, H., Fischer, B., Usadel, K.H., Seifried, E., Kaltwasser, P. & Badenhoop, K. (1998) CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens, 51, 62-66.
18. Ueda, H., Howson, J.M., Esposito, L., Reward, J., Snook, H., Chamberlain, G., Rainbow, D.B., Hunter, K.M., Smith, A.N., Di Genova, G., Herr, M.H., Dahlman, I., Payne, F., Smyth, D., Lowe, C., Twells, R.C., Howlett, S., Healy, B., Nutland, S., Rance, H.E., Everett, V., Smink, L.J., Lam, A.C., Cordell, H.J., Walker, N.M., Bordin, C., Hulme, J., Motzo, C., Cucca, F., Hess, J.F., Metzker, M.L., Rogers, J., Gregory, S., Allahabadia, A., Nithiyananthan, R., Tuomilehto-Wolf, E., Tuomilehto, J., Bingley, P., Gillespie, K.M., Undlien, D.E., Ronningen, K.S., Guja, C., Ionescu-Tirgoviste, C., Savage, D.A., Maxwell, A.P., Carson, D.J., Patterson, C.C., Franklyn, J.A., Clayton, D.G., Peterson, L.B., Wicker, L.S., Todd, J.A. & Gough, S.C. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506-511.
19. Vaidya, B., Imrie, H., Perros, P., Dickinson, J., McCarthy, M.I., Kendall-Taylor, P. & Pearce, S.H. (1999) Cytotoxic T lymphocyte antigen-4 (CLTA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet, 354, 743-744.
20. Vaidya, B., Oakes, E.J., Imrie, H., Dickinson, A.J., Perros, P., Kendall-Taylor, P. & Pearce, S.H. (2003) CLTA4 and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphism but not with the promoter polymorphism. Clinical Endocrinology, 58, 732-735.